[{"Assets_0_Q3_USD":"9165243000.0","CIK":"1593034","CommonStockSharesConverted_0_Q3_shares":"230288796.0","CommonStockSharesOutstanding_0_Q3_shares":"226802609.0","Country":"Ireland","EarningsPerShareBasic_1_Q3_USD":"-0.33","EarningsPerShareBasic_3_Q3_USD":"0.28","EarningsPerShareDiluted_1_Q3_USD":"-0.33","EarningsPerShareDiluted_3_Q3_USD":"0.28","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"640358301.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"289443000.0","NetIncomeLossConverted_1_Q3_USD":"-75887000.0","NetIncomeLossConverted_3_Q3_USD":"64601000.0","OfficialName":"Endo International plc Ordinary Shares","RevenuesConverted_1_Q3_USD":"634860000.0","RevenuesConverted_3_Q3_USD":"2142853000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"-782482000.0","Ticker":"ENDP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"230040000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"233379000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"230040000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"228985000.0","filed":"20201106","footnote":null,"form":"10-Q","fp":"Q3","fy":"2020.0","name":"ENDO INTERNATIONAL PLC","period":"20200930","qtrs":"1","uom":"USD"}]